Search Results - "Bottecchia, Marcelle"

  • Showing 1 - 17 results of 17
Refine Results
  1. 1

    Hepatitis B virus genotypes and resistance mutations in patients under long term lamivudine therapy: characterization of genotype G in Brazil by Bottecchia, Marcelle, Souto, Francisco J D, O, Kycia M R, Amendola, Marcia, Brandão, Carlos E, Niel, Christian, Gomes, Selma A

    Published in BMC microbiology (22-01-2008)
    “…Lamivudine is an oral nucleoside analogue widely used for the treatment of chronic hepatitis B. The main limitation of lamivudine use is the selection of…”
    Get full text
    Journal Article
  2. 2

    Does treatment of hepatitis B virus (HBV) infection reduce hepatitis delta virus (HDV) replication in HIV-HBV-HDV-coinfected patients? by SHELDON, Julie, RAMOS, Belén, TORO, Carlos, RIOS, Pilar, MARTINEZ-ALARCON, José, BOTTECCHIA, Marcelle, ROMERO, Miriam, GARCIA-SAMANIEGO, Javier, SORIANO, Vincent

    Published in Antiviral therapy (2008)
    “…Hepatitis delta virus (HDV) has a unique replication process that requires coinfection with hepatitis B virus (HBV). Treatment is currently limited to…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Management of hepatitis B virus co-infection on and off antiretroviral therapy by Soriano, Vincent, Vispo, Eugenia, Bottecchia, Marcelle, Sheldon, Julie, Tuma, Paula, Garcia-Samaniego, Javier, Barreiro, Pablo

    Published in Current HIV/AIDS reports (01-05-2008)
    “…Chronic hepatitis B virus (HBV) infection is recognized in 5% to 10% of persons with HIV. Co-infected individuals show an accelerated course of HBV-associated…”
    Get full text
    Journal Article
  6. 6

    Detection of hepatitis B virus genotype A3 and primary drug resistance mutations in African immigrants with chronic hepatitis B in Spain by BOTTECCHIA, Marcelle, MADEJON, Antonio, PUENTE, Sabino, GARCIA-SAMANIEGO, Javier, RIVAS, Pablo, HERRERO, Dolores, SORIANO, Vincent

    Published in Journal of antimicrobial chemotherapy (01-03-2011)
    “…Universal vaccination and antiviral therapy have reduced chronic hepatitis B virus (HBV) in natives in the Western world. However, immigration from high HBV…”
    Get full text
    Journal Article
  7. 7

    Hepatitis B virus genotype A2 harbours an L217R polymorphism which may account for a lower response to adefovir by Bottecchia, Marcelle, Madejón, Antonio, Sheldon, Julie, García-Samaniego, Javier, Barreiro, Pablo, Soriano, Vincent

    Published in Journal of antimicrobial chemotherapy (01-09-2008)
    “…Hepatitis B virus (HBV) infection is a major health problem worldwide. The World Health Organization estimates that more than 400 million people are affected…”
    Get full text
    Journal Article
  8. 8

    Emerging drugs for hepatitis C by Soriano, Vincent, Madejon, Antonio, Vispo, Eugenia, Labarga, Pablo, Garcia-Samaniego, Javier, Martin-Carbonero, Luz, Sheldon, Julie, Bottecchia, Marcelle, Tuma, Paula, Barreiro, Pablo

    Published in Expert opinion on emerging drugs (01-03-2008)
    “…Chronic hepatitis C virus (HCV) infection remains a global health threat with approximately 200 million carriers worldwide. Current treatment consists of the…”
    Get more information
    Journal Article
  9. 9

    The implications of antiviral drugs with activity against hepatitis B virus and HIV by Bottecchia, Marcelle, Garcia-Samaniego, Javier, Soriano, Vincent

    Published in Current opinion in infectious diseases (01-12-2007)
    “…PURPOSE OF REVIEWAround 10% of individuals infected with HIV suffer from chronic hepatitis B virus infection. This represents at least 4 million people…”
    Get full text
    Journal Article
  10. 10

    Lamivudine resistance and other mutations in the polymerase and surface antigen genes of hepatitis B virus associated with a fatal hepatic failure case by Bottecchia, Marcelle, Ikuta, Nilo, Niel, Christian, Araujo, Natalia M, Ó, Kycia MR, Gomes, Selma A

    Published in Journal of gastroenterology and hepatology (01-01-2008)
    “…Background and Aim:  Resistance to lamivudine therapy of chronic hepatitis B virus (HBV) infection occurs by mutation in the YMDD motif of the reverse…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Lamivudina por tempo prolongado no tratamento da hepatite B crônica no estado de Mato Grosso by Souto, Francisco José Dutra, Pirajá, Ana Carolina da Silva, Silva, Graciana Soares da, Bottecchia, Marcelle, Gomes, Selma Andrade

    “…Para avaliar resultados do tratamento da hepatite B crônica com lamivudina, 100mg ou 150mg diários, foram acompanhados 34 pacientes em um serviço em Cuiabá,…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Long-term use of lamivudine for treating chronic hepatitis B in the State of Mato Grosso by Souto, Francisco José Dutra, Pirajá, Ana Carolina da Silva, da Silva, Graciana Soares, Bottecchia, Marcelle, Gomes, Selma Andrade

    “…To assess the results from lamivudine treatment (100 mg or 150 mg) for chronic hepatitis B, 34 patients were followed at a clinic in Cuiabá, Mato Grosso,…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Lamivudina por tempo prolongado no tratamento da hepatite B crônica no estado de Mato Grosso by Souto, Francisco José Dutra, Pirajá, Ana Carolina da Silva, Silva, Graciana Soares da, Bottecchia, Marcelle, Gomes, Selma Andrade

    “…Para avaliar resultados do tratamento da hepatite B crônica com lamivudina, 100mg ou 150mg diários, foram acompanhados 34 pacientes em um serviço em Cuiabá,…”
    Get full text
    Journal Article